2022-RA-653-ESGO The impact of histology, prior therapy, and dMMR status on lenvatinib + pembrolizumab outcomes in patients with advanced endometrial cancer: A subgroup analysis of Study 309/KEYNOTE-775
Articles > Article · 2022
Authors: Domenica Lorusso, Vicky Makker, Antonio Casado Herraez, Bradley J Monk, Helen Mackay, Alessandro D Santin, David S Miller, Richard Moore, Sally Baron-Hay, Isabelle Ray-Coquard, Ronnie Shapira-Frommer, Kimio Ushijima, Kan Yonemori, Yong Man Kim, Eva M Guerra Alia, Ulus Ali ŞANLI, Jie Huang, Jodi McKenzie, Gianmaria Barresi, Nicoletta Colombo
International Journal of Gynecological Cancer, International, WoS, 2022, vol 32, pp A102-A102